This is one of the most rapidly growing diseases in the world.

Other devices must be recalibrated every few hours or days. This is time-consuming and annoying. Our system only needs to be recalibrated every month and the process is very simple.

With careful and accurate monitoring, the patients can decide the optimal timing to take their medicine, or can refer themselves in time to a doctor if the results show an aggravation or deterioration in condition.

Developing the three different technologies was relatively easy. The hard part was combining them into a single device with a single interface and point of communication between them. It took quite a lot of effort to overcome this problem, but eventually we did.

The human body is very complex and the accuracy levels required from blood glucose measurements must be very high. A single technology was not enough to create the necessary accuracy.

The diabetes market desperately needs a non-invasive glucose level monitor. A non-invasive device approved by CE and the FDA will be easily sold in very large quantities worldwide.

We realized there was an urgent need for such a product, and that it was a very large market, giving us all the reason in the world to work on it.